clonic epilepsy without Lafora bodies has been reported (Matthews et al., 1969) .
In a second group, some patients with myoclonic epilepsy have had cerebellar ataxia or extrapyramidal signs suggesting involvement of the olivodentate system by primary degenerative diseases. Dyssynergia cerebellaris myoclonica (Hunt, 1921) is included in this category as well as patients with Friedreich's ataxia who develop myoclonus and epilepsy. The onset occurs from the second decade onwards and runs a more benign course with less involvement of higher cerebral functions.
The third group of patients have an underlying lipidosis which is almost invariably juvenile amaurotic familial idiocy. The non-infantile types of amaurotic familial idiocy have become known by the term neuronal ceroid lipofuscinosis (Zeman, 1974) since the identification of the stored neuronal pigments. Sjogren (1931) clearly distinguished between infantile amaurotic familial idiocy (Tay-Sachs disease) and the juvenile form. In the latter he recognized the characteristic syndrome of epilepsy beginning between 6 and 12 years of age, with progressive extrapyramidal rigidity. Although most patients with juvenile amaurotic familial idiocy have fits, in a few instances the degree of associated myoclonus has suggested progressive myoclonic epilepsy. Marinesco (1925) reported a case of progressive myoclonic epilepsy in a boy aged 6 years with amaurotic familial idiocy in whom the brain showed lipid deposits in many ganglion cells with the additional feature of small rounded well-defined bodies, similar to the nucleus, in the cytoplasm. Similar cases have been described by Liebers (1927) , Haddenbrock (1950 ), Marchand et al. (1956 ), de Vries and Amir (1964 , and Klinken-Rasmussen and Dyggve (1965) . Diezel (1957) , reinvestigating Haddenbrock's case and reporting another, demonstrated that the small round bodies consisted predominantly of protein with small amounts of glycolipid. Seitelberger et al. (1967) defined this 'myoclonic variant of amaurotic familial idiocy' when he reported eight patients, aged between 2 and 10 years who presented with grand mal fits and cerebellar ataxia followed by psychomotor deterioration, myoclonus, blindness with optic atrophy and retinitis pigmentosa, and who finally died of dementia and cachexia. They showed generalized neuronal lipid storage, with protein type inclusion bodies in the cells of the thalamus, subthalamic nucleus, substantia nigra, dentate nucleus, inferior olive, and locus caeruleus. It should be noted that these bodies are quite different from Lafora bodies, which consist of mucopolysaccharide in the form of polyglucosans (Yokoi et al., 1968) .
Two patients with progressive myoclonic epilepsy due to an underlying lipidosis do not fall into the type described by Seitelberger et al. (1967) . One, with features of amaurotic familial idiocy-namely, cherry red spots in the fundi, optic atrophy, and a family history of blindness and death in infancy-also had cystic changes in radiographs of long bones, pathological fractures, and storage cells in the sternal bone marrow which morphologically resembled Gaucher cells. This patient developed generalized myoclonus from the age of 10 years, grand mal seizures at 23 years, and finally died at 31 years of age with minimal evidence of dementia (Glasgow, 1957; Halliday, 1967) . The patient reported by Pallis et al. (1967) In 1973 his fits were entirely nocturnal and were accompanied by urinary incontinence. Those observed in hospital were of sudden onset with rigidity of all four limbs and body followed by a clonic phase lasting several minutes. His major disability was his myoclonic jerks which prevented him from writing and caused him to take an hour over dressing. His treatment consisted of primidone, phenytoin sodium, sulthiame, nitrazepam, diazepam, and methylphenidate.
He had slow slurred speech with a mild nominal dysphasia. His gait was normal, but for very marked myoclonic jerking which involved his face, arms, and legs. The myoclonus was increased by voluntary movement such as drinking from a cup or attempting to adjust his spectacles, by sudden noises, lights, tactile stimuli, and when his eyes were closed. His visual acuity, fields, and fundi were normal but saccadic eye movements were slow in all directions (this will be reported separately). Muscle tone, power, reflexes, and sensation were normal but he had finger-nose and heel-shin ataxia which was thought to be mainly due to his myoclonus. His cardiovascular system, lungs, and abdomen were normal and, in particular, no spleen was palpable.
His electroencephalogram and cerebral evoked responses were unchanged. Other investigations were: haemoglobin 9.4 g/dl, sedimentation rate 7 mm/h, white cell count 2 400 mm-3, ( (Fig. 2) . Histochemical examination of the marrow confirmed the numerous foamy cells which morphologically resembled those seen in late onset GMI gangliosidosis or Gaucher's disease. The betagalactosidase activity of peripheral blood leucocytes was 205 nmol/mg protein/h (100-400) and betaglucosidase activity of fibroblasts was 35 nmol/mg protein/h (100-500), consistent with Gaucher's disease.
Since discharge the patient has been unable to keep his employment and it has been necessary to admit him to an institution with special facilities for epileptics. The recent introduction of clonazepam has improved the control of his myoclonic jerks and it has been possible to reduce his other anticonvulsants.
Since Brady et al. (1965) demonstrated the deficiency of beta-glucosidase, the enzyme which cleaves glucose from glucosyl ceramide (glucocerebroside), the diagnosis of Gaucher's disease has relied upon evidence of reduced enzyme activity rather than the finding of the typical Gaucher cell. The presence of the latter provides only a tentative diagnosis, as similar cells are found in GMI gangliosidosis where there is a deficiency of beta-galactosidase (Okada and O'Brien, 1968) , and in chronic myeloid leukaemia (Kattlove et al., 1969) .
In the patient reported here, the storage cells in the bone marrow, the elevated serum acid phosphatase, normal beta-galactosidase, and deficient betaglucosidase activity point to an unequivocal diagnosis of Gaucher's disease. The absence of a palpable spleen delayed diagnosis and is unusual, although well recognized (Morgans, 1947; Maloney and Cumings, 1960) . The diagnosis of progressive myoclonic epilepsy is justified on the grounds of the extensive myoclonus, and grand mal seizures and the giant cerebral evoked potentials. The degree of intellectual deterioration is difficult to assess because of the effect of the anticonvulsant drugs and also the absence of a formal assessment before the onset of the illness. If present it has been of only a mild degree in 20 years.
If one disregards the neurological features of the present case, the age of onset, prolonged survival, pancytopenia, and Ashkenazi Jewish origin suggest that the patient is suffering from the chronic adult form of Gaucher's disease. However absence ofneurological involvement is the sine qua non for classification in the adult or non-neuronopathic type of Gaucher's disease as opposed to the infantile form where neurological signs are the rule and death occurs under 2 years of age. There is a further small group known as juvenile or subacute neuronopathic Gaucher's disease where survival into the second decade is known. Frederickson and Sloan (1972) have reviewed 25 cases, 12 of whom were reported from Sweden by Hillborg (1959) . The neurological features of this group were mental retardation, psychotic behaviour disturbances, generalized rigidity, jerky movements, epilepsy, and abnormal electroencephalograms. The jerky movements involved the eyes, mouth, and limbs, but were not described as myoclonic in nature (Herrlin and Hillborg, 1962) . The age of onset was in the first six months of life with survival up to 20 years, although six died in the first three years. Of six studied in detail, five patients had a pancytopenia and all had normal radiological examinations before splenectomy.
Despite the absence of neurological signs, by definition, in adult Gaucher's disease, there have been several case reports of neurological involvement after the first decade (van Bogaert and Frohlich, 1939; Davison, 1942 (Teilum, 1944; Morrison and Lane, 1955) , spinal cord (Davison, 1942) , and meninges (Chang-lo et al., 1967) .
Even considering the pattern of involvement of the nervous system in the infantile (Norman et al., 1956) and juvenile forms of Gaucher's disease (Bird, 1948) , there is no evidence of a specific pattern to account for the occurrence of progressive myoclonic epilepsy. The same can be said for the other lipidoses and Lafora body disease where the changes are so diffuse. This contrasts with the frequent finding of dentate and olivary atrophy in cases of the system degeneration type (Meyer, 1963) .
Although the long term prognosis for the subject of this case report must be poor, he has already survived more than 20 years since his seizures began. His degree of intellectual impairment is mild and, provided that a drug is found which will control his epilepsy and myoclonus without excessive sideeffects, it is conceivable that he could return to some form of useful employment. The advent of clonazepam has provided some hope in this direction and early reports of its use in progressive myoclonic epilepsy are favourable (Laitinen and Toivakka, 1973) .
In the clinical context of a patient with persistent myoclonus and epilepsy, Gaucher's disease must be considered among the lipidoses which cause this disorder. Parental consanguinity, Ashkenazi Jewish origins, and splenomegaly will suggest the diagnosis and an elevated serum acid phosphatase and Gaucher cells in the sternal bone marrow are virtually diagnostic. The demonstration of beta-glucosidase deficiency in fibroblasts is confirmatory. Foley is also acknowledged.
